Liu, Xiangxiang
Yu, Hong-jie
Gao, Yan
Zhou, Jing
Zhou, Mingchao
Wan, Li
Xiong, Feng
Zhao, Jingpu
He, Qi-qiang
Wang, Yulong
Funding for this research was provided by:
National Key Research and Development Program of China (2020YFC2008700, 2020YFC2008700, 2020YFC2008700)
China Postdoctoral Science Foundation (2021M692215)
Guangdong Basic and Applied Basic Research Foundation (2020A1515111134)
Article History
Received: 6 April 2021
Accepted: 31 August 2021
First Online: 16 September 2021
Declarations
:
: This study protocols were approved by the Medical Ethics Committees of Shenzhen Second People’s Hospital (Project identification code: 20180926006) on October 8, 2018 (protool version 1), then amendment on October 29, 2018 (increase the sample, completed measurements; version 2). Both Protocol versions 1 and version 2 conserved the same code of 20180926006. The study was registered in the Chinese Clinical Trial Registry (No.: ChiCTR2000034067) on June 22, 2020. All inpatients or their proxies were invited to participate in this study after obtaining the informed consent. And all the authors confirmed that all methods were carried out in accordance with relevant guidelines and regulations.
: All inpatients or their proxies’ consent to publish this study.
: The authors declare that they have no competing interests.